Neurotechnology developers design and engineer tools that interact directly with the nervous system to restore, enhance, or monitor brain and neural functions. Their work spans a range of innovations including brain-computer interfaces (BCIs), neural implants, neuroprosthetics, and non-invasive stimulation devices. These professionals merge principles from neuroscience, bioengineering, and computer science to translate neural signals into actionable data or motor outputs. They create technologies that enable individuals with paralysis to control external devices using only brain activity or help patients with hearing or vision loss through sensory substitution systems.
Beyond assistive applications, neurotechnology developers are advancing tools for cognitive enhancement, neuromodulation, and personalized neurotherapy. They also build diagnostic platforms capable of detecting subtle neurophysiological patterns in disorders like epilepsy, depression, or Parkinson’s disease. Safety, signal fidelity, and long-term compatibility are core design challenges, often requiring innovative materials and algorithms. Developers often work in clinical trials and regulatory frameworks to ensure that new technologies meet rigorous safety and efficacy standards. Their efforts are transforming the landscape of neurological care, pushing the boundaries of what’s possible in neural restoration and brain-machine integration. As neurotechnology becomes more integrated into everyday healthcare, these specialists continue to shape its future through both technical breakthroughs and ethical foresight.
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Study of resilience in cases of incest, father-daughter, step-father and step-daughter in the pre-pubber and puberous period among adult women and mothers: How to overcome the traumatisms of an incestuous relationship?
Daniele Lapointe, Laval University, Canada
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom